GlassScriptPhysician profile
Avinash Kolli
NPI 1104404219
$1,173.12
in general payments reported to CMS, 2019-2025
9 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $375 · 2024: $677 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $229.47 | 2024-2025 | |
| Biogen, INC. | $215.65 | 2023-2024 | Spinraza, Vumerity, Tysabri |
| Livanova USA, INC. | $132.97 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Amgen INC. | $125.00 | 2024 | Uplizna |
| Csl Behring | $121.12 | 2023 | Kcentra |
| Alexion Pharmaceuticals, INC. | $114.75 | 2023 | Soliris |
| Neurelis, INC. | $114.06 | 2024 | Valtoco |
| Celgene Corporation | $100.13 | 2023 | |
| Emd Serono, INC. | $19.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Kolli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.